 | • レポートコード：MRC2303F0084 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、225ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートでは、2021年に301.29百万ドルであった世界のバイオプロセス検証市場規模が、2022年に345.00百万ドルになり、2027年まで年平均14.68%で成長して685.43百万ドルに拡大すると予測しています。本レポートは、バイオプロセス検証の世界市場について調べ、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、試験別（互換テストサービス、抽出物/浸出物試験サービス、インテグリティ試験サービス、微生物試験サービス）分析、プロセスコンポーネント別（バイオリアクター、フィルターエレメント、凍結・解凍プロセスバッグ、メディアコンテナ・バッグ、その他）分析、エンドユーザー別（バイオテクノロジー企業、開発・製造受託機関、製薬会社）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などを以下の構成でまとめております。また、Almac Group、BiOZEEN、Cobetter Filtration Equipment Co., Ltd.、Doc S.r.l、Eurofins Scientific、Hangzhou Anow Microfiltration Co., Ltd.、Meissner Filtration Products, Inc.、Merck KGaA、Pall Corporation、Porvair plc、Sartorius Stedim Biotech S.A.、SGS S.A.、Thermo Fisher Scientific, Inc、Tianshan Precision Filter Material Co., Ltd.、Toxikon Corporationなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のバイオプロセス検証市場規模：試験別 - 互換テストサービスの市場規模 - 抽出物/浸出物試験サービスの市場規模 - インテグリティ試験サービスの市場規模 - 微生物試験サービスの市場規模 ・世界のバイオプロセス検証市場規模：プロセスコンポーネント別 - バイオリアクターにおける市場規模 - フィルターエレメントにおける市場規模 - 凍結・解凍プロセスバッグにおける市場規模 - メディアコンテナ・バッグにおける市場規模 - その他における市場規模 ・世界のバイオプロセス検証市場規模：エンドユーザー別 - バイオテクノロジー企業における市場規模 - 開発・製造受託機関における市場規模 - 製薬会社における市場規模 ・世界のバイオプロセス検証市場規模：地域別 - 南北アメリカのバイオプロセス検証市場規模 アメリカのバイオプロセス検証市場規模 カナダのバイオプロセス検証市場規模 ブラジルのバイオプロセス検証市場規模 … - アジア太平洋のバイオプロセス検証市場規模 日本のバイオプロセス検証市場規模 中国のバイオプロセス検証市場規模 インドのバイオプロセス検証市場規模 韓国のバイオプロセス検証市場規模 台湾のバイオプロセス検証市場規模 … - ヨーロッパ/中東/アフリカのバイオプロセス検証市場規模 イギリスのバイオプロセス検証市場規模 ドイツのバイオプロセス検証市場規模 フランスのバイオプロセス検証市場規模 ロシアのバイオプロセス検証市場規模 … - その他地域のバイオプロセス検証市場規模 ・競争状況 ・企業情報 |
The Global Bioprocess Validation Market size was estimated at USD 301.29 million in 2021 and expected to reach USD 345.00 million in 2022, and is projected to grow at a CAGR 14.68% to reach USD 685.43 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Bioprocess Validation to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Test Type, the market was studied across Compatibility Testing Services, Extractables/Leachables Testing Services, Integrity Testing Services, and Microbiological Testing Services.
Based on Process Component, the market was studied across Bioreactors, Filter Elements, Freezing and Thawing Process Bags, Media Containers and Bags, Mixing Systems, and Transfer Systems.
Based on End User, the market was studied across Biotechnology Companies, Contract Development & Manufacturing Organizations, and Pharmaceutical Companies.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Bioprocess Validation market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Bioprocess Validation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Bioprocess Validation Market, including Almac Group, BiOZEEN, Cobetter Filtration Equipment Co., Ltd., Doc S.r.l, Eurofins Scientific, Hangzhou Anow Microfiltration Co., Ltd., Meissner Filtration Products, Inc., Merck KGaA, Pall Corporation, Porvair plc, Sartorius Stedim Biotech S.A., SGS S.A., Thermo Fisher Scientific, Inc, Tianshan Precision Filter Material Co., Ltd., and Toxikon Corporation.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Bioprocess Validation Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Bioprocess Validation Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Bioprocess Validation Market?
4. What is the competitive strategic window for opportunities in the Global Bioprocess Validation Market?
5. What are the technology trends and regulatory frameworks in the Global Bioprocess Validation Market?
6. What is the market share of the leading vendors in the Global Bioprocess Validation Market?
7. What modes and strategic moves are considered suitable for entering the Global Bioprocess Validation Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Precise safety and quality regulations
5.1.1.2. Rising demand for biopharmaceuticals
5.1.1.3. Growing need for outsourcing bioprocess validation
5.1.1.4. Increasing life science R&D expenditure
5.1.2. Restraints
5.1.2.1. Issues associated with extractables & leachables
5.1.3. Opportunities
5.1.3.1. Growth opportunities in Asia Pacific and Latin American countries
5.1.3.2. Patent expiry
5.1.4. Challenges
5.1.4.1. Development of new validation methods for next-generation bioproducts
5.1.4.2. Waste disposal
5.2. Cumulative Impact of COVID-19
6. Bioprocess Validation Market, by Test Type
6.1. Introduction
6.2. Compatibility Testing Services
6.3. Extractables/Leachables Testing Services
6.4. Integrity Testing Services
6.5. Microbiological Testing Services
7. Bioprocess Validation Market, by Process Component
7.1. Introduction
7.2. Bioreactors
7.3. Filter Elements
7.4. Freezing and Thawing Process Bags
7.5. Media Containers and Bags
7.6. Mixing Systems
7.7. Transfer Systems
8. Bioprocess Validation Market, by End User
8.1. Introduction
8.2. Biotechnology Companies
8.3. Contract Development & Manufacturing Organizations
8.4. Pharmaceutical Companies
9. Americas Bioprocess Validation Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Bioprocess Validation Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Bioprocess Validation Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Almac Group
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. BiOZEEN
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Cobetter Filtration Equipment Co., Ltd.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Doc S.r.l
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Eurofins Scientific
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Hangzhou Anow Microfiltration Co., Ltd.
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Meissner Filtration Products, Inc.
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Merck KGaA
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Pall Corporation
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Porvair plc
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Sartorius Stedim Biotech S.A.
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. SGS S.A.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Thermo Fisher Scientific, Inc
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Tianshan Precision Filter Material Co., Ltd.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Toxikon Corporation
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
